Akers Biosciences Further Extends Outsourced US Distribution Capabilities for Heparin PF4 Rapid Test
03 juil. 2018 07h00 HE
|
Akers Biosciences Inc
THOROFARE, N.J., July 03, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies,...